Citations

Mayo Clinic

Clear

224 citation(s) found for "Ertekin-Taner, Nilufer".

P4‐049: IDENTIFICATION OF CELL‐SPECIFIC DIFFERENTIALLY EXPRESSED GENES IN ALZHEIMER'S DISEASE
Wang, Xue , Allen, Mariet , Carrasquillo, Minerva M. , Li, Shaoyu , Asmann, Yan W. , Ertekin‐Taner, Nilüfer , Carrasquillo, Minerva M. , Burgess, Jeremy D.

Alzheimer's & Dementia | October 22, 2018 | Volume: 14 | Issue: 7S_Part_27 | Pages: No page available

10.1016/j.jalz.2018.06.2451 Get It

P3‐458: CLINICOPATHOLOGIC DIFFERENCES WITHIN ALZHEIMER'S DISEASE CASES FROM THE FLORIDA AUTOPSIED MULTI‐ETHNIC (FLAME) STUDY
Santos, Octavio A. , Duara, Ranjan , Lucas, John A. , Greig‐Custo, Maria T., Liesinger, Amanda M., Al‐Shaikh, Fadi S. Hanna , Ertekin‐Taner, Nilüfer , Pedraza, Otto , Graff‐Radford, Neill R. , Duara, Ranjan , Ross, Owen A. , Dickson, Dennis W. , Murray, Melissa E.

Alzheimer's & Dementia | October 22, 2018 | Volume: 14 | Issue: 7S_Part_24 | Pages: No page available

10.1016/j.jalz.2018.06.1822 Get It

P3‐378: EFFECT OF AGE, GENDER, ETHNICITY, COGNITION AND APOE GENOTYPE ON AMYLOID LOAD AMONG NORMAL, MCI AND MILD DEMENTIA SUBJECTS USING [F‐18] FLORBETABEN
Duara, Ranjan , Lizarraga, Gabriel , Adjouadi, Malek , Barker, Warren , Greig‐Custo, Maria T., Peñate, Ailyn, Hanson, Kevin , Ertekin‐Taner, Nilüfer , Vaillancourt, David E. , Santi, Susan De , Golde, Todd E. , Duara, Ranjan , Loewenstein, David , Marsiske, Michael , Burke, Shanna L. , DeKosky, Steven T.

Alzheimer's & Dementia | October 22, 2018 | Volume: 14 | Issue: 7S_Part_23 | Pages: No page available

10.1016/j.jalz.2018.06.1740 Get It

P3‐132: GENOME‐WIDE ASSOCIATION STUDY OF CEREBRAL MICROBLEEDS AND INFARCTION IDENTIFIES CANDIDATE GENES FOR VASCULAR RISK IN DEMENTIA
Carrasquillo, Minerva M. , Reddy, Joseph S. , Allen, Mariet , Reyes, Denise A., Graff‐Radford, Jonathan , Kosel, Matthew , Gregory, Jenkins D., Nguyen, Thuy , Lincoln, Sarah, Malphrus, Kimberly G., Lowe, Val J. , Petersen, Ronald C. , Ertekin‐Taner, Nilüfer , Carrasquillo, Minerva M. , McDonnell, Shannon K. , Crook, Julia E. , Jack, Clifford R. , Knopman, David S. , Kantarci, Kejal , Bu, Guojun

Alzheimer's & Dementia | October 22, 2018 | Volume: 14 | Issue: 7S_Part_21 | Pages: No page available

10.1016/j.jalz.2018.06.1489 Get It

P3‐129: MAPPING FUNCTIONAL REGULATORY VARIANTS AT ALZHEIMER'S DISEASE RISK LOCI
Allen, Mariet , Bredenberg, Jenny M., Reddy, Joseph S. , Sarangi, Vivekananda , Carrasquillo, Minerva M. , Lincoln, Sarah, Nguyen, Thuy , Malphrus, Kimberly G., Asmann, Yan W. , Ertekin‐Taner, Nilüfer , Carrasquillo, Minerva M. , Wang, Xue, Dickson, Dennis W.

Alzheimer's & Dementia | October 22, 2018 | Volume: 14 | Issue: 7S_Part_21 | Pages: No page available

10.1016/j.jalz.2018.06.1486 Get It

P2‐290: ELECTROENCEPHALOGRAM FINDINGS IN PATIENTS WITH POSTERIOR CORTICAL ATROPHY
Stephens, Alana, Graff‐Radford, Neill R. , Carrasquillo, Minerva M. , Tatum, William O. , Ertekin‐Taner, Nilüfer , Goldstein, Eric , Carrasquillo, Minerva M. , Boeve, Bradley F. , Feyissa, Anteneh M.

Alzheimer's & Dementia | October 22, 2018 | Volume: 14 | Issue: 7S_Part_15 | Pages: No page available

10.1016/j.jalz.2018.06.979 Get It

P2‐141: CHR17Q21 H2 HAPLOTYPE STRATIFIED GWAS REVEALS DIFFERENTIAL ASSOCIATION FOR AD RISK VARIANTS
Strickland, Samantha L. , Reddy, Joseph S. , Allen, Mariet , N’Songo, Aurelie, Corda, M, Ballard, Travis, Boehme, Kevin L. , Kauwe, John, Ertekin‐Taner, Nilüfer , ADGC, Burgess, Jeremy D. , Corda, Morgane M., Mukherjee, Shubhabrata , Crane, Paul K. , ADGC

Alzheimer's & Dementia | October 22, 2018 | Volume: 14 | Issue: 7S_Part_13 | Pages: No page available

10.1016/j.jalz.2018.06.827 Get It

P1‐492: SELECTIVE VULNERABILITY OF THE CHOLINERGIC SYSTEM IN ALZHEIMER'S DISEASE SUBTYPES
Al‐Shaikh, Fadi S. Hanna , Graff‐Radford, Neill R. , Liesinger, Amanda M., Ertekin‐Taner, Nilüfer , Pedraza, Otto , Duara, Ranjan , Ferman, Tanis J. , Ross, Owen A. , Duara, Ranjan , Dickson, Dennis W. , Murray, Melissa E.

Alzheimer's & Dementia | October 22, 2018 | Volume: 14 | Issue: 7S_Part_9 | Pages: No page available

10.1016/j.jalz.2018.06.502 Get It

P1‐160: ABI3 AND PLCG2 AS RISK FACTORS FOR ALZHEIMER'S DISEASE IN CAUCASIANS AND AFRICAN AMERICANS
Conway, Olivia J., Carrasquillo, Minerva M. , Bredenberg, Jenny M., Reddy, Joseph S. , Younkin, Curtis, Allen, Mariet , Nguyen, Thuy , Lincoln, Sarah, Malphrus, Kimberly G., Duara, Ranjan , Custo, María T. Greig, Petersen, Ronald C. , Ertekin‐Taner, Nilüfer , Carrasquillo, Minerva M. , Duara, Ranjan , Dickson, Dennis W. , Graff, Caroline

Alzheimer's & Dementia | October 22, 2018 | Volume: 14 | Issue: 7S_Part_6 | Pages: No page available

10.1016/j.jalz.2018.06.164 Get It

TLR5 decoy receptor as a novel anti-amyloid therapeutic for Alzheimer’s disease
Chakrabarty, Paramita , Li, Andrew, Ladd, Thomas B., Strickland, Michael R. , Koller, Emily J., Burgess, Jeremy D. , Funk, Cory C. , Allen, Mariet , Yaroshenko, Mariya, Wang, Xue , Younkin, Curtis, Reddy, Joseph S. , Lohrer, Benjamin , Mehrke, Leonie S. , Moore, Brenda D. , Ceballos‐Diaz, Carolina, Rosario, Awilda M., Medway, Christopher, Janus, Christopher, Li, Hongdong , Giasson, Benoit I. , Price, Nathan D. , Younkin, Steven G. , Ertekin‐Taner, Nilüfer , Golde, Todd E. , Reddy, Joseph , Mehrke, Leonie, Price, Nathan D , Golde, Todd E , Cruz, Pedro E. , Wang, Xue, Liu, Xuefei , Li, Hong-Dong, Dickson, Dennis W.

Journal of Experimental Medicine | August 29, 2018 | Volume: 215 | Issue: 9 | Pages: 2247-2264

10.1084/jem.20180484 | PMID 30158114 Get It

There is considerable interest in harnessing innate immunity to treat Alzheimer’s disease (AD). Here, we explore whether a decoy receptor strategy using the ectodomain of select TLRs has therapeutic potential in AD. AAV-mediated expression of human TLR5 ectodomain (sTLR5) alone or fused to human IgG4 Fc (sTLR5Fc) results in robust attenuation of amyloid β (Aβ) accumulation in a mouse model of Alzheimer-type Aβ pathology. sTLR5Fc binds to oligomeric and fibrillar Aβ with high affinity, forms complexes with Aβ, and blocks Aβ toxicity. Oligomeric and fibrillar Aβ modulates flagellin-mediated activation of human TLR5 but does not, by itself, activate TLR5 signaling. Genetic analysis shows that rare protein coding variants in human TLR5 may be associated with a reduced risk of AD. Further, transcriptome analysis shows altered TLR gene expression in human AD. Collectively, our data suggest that TLR5 decoy receptor–based biologics represent a novel and safe Aβ-selective class of biotherapy in AD.